FDA approves HA filler portfolio
Pharmaceutical company Merz Aesthetics has expanded its hyaluronic acid filler range in the US, announcing US Food and Drug Administration (FDA) approval for Belotero Volume and Belotero Intense. According to
Pharmaceutical company Merz Aesthetics has expanded its hyaluronic acid filler range in the US, announcing US Food and Drug Administration (FDA) approval for Belotero Volume and Belotero Intense. According to
Pharmaceutical company Galderma has released topline results from a randomised study evaluating its hyaluronic acid filler, Restylane Volyme, for moderate-to-severe temple hollowing. The study, involving 162 patients in China, found
Dr Aggie Zatonska argues that recent reports around extended filler longevity are no cause for concern The prolonged persistence of fillers in the body, as evidenced by advanced imaging techniques
Four Teoxane UK trainers share their advice on utilising hyaluronic acid fillers. Hyaluronic acid (HA) fillers have revolutionised the field of medical aesthetics. With their unparalleled versatility, HA fillers provide
Cosmetic and dermatology nurse practitioner Anna Baker details the anatomical features of the temple for safe and successful dermal filler placement.
In the first of a two-part article, Dr Souphiyeh Samizadeh discusses the basic characteristics of hyaluronic acid fillers to aid product selection
Miss Rachna Murthy and Professor Jonathan Roos explore the emergency management of filler-induced vision loss
The UK distributor of IBSA Derma’s products, HA-Derma, is hosting a free webinar on May 17 regarding complications arising with hyaluronic acid (HA) injectable treatments.
Pharmaceutical company Sinclair Pharma is launching a new hyaluronic acid (HA) facial filler called MaiLi.
Aesthetic practitioner Dr MJ Rowland-Warmann has recorded a hypersensitivity reaction to hyaluronic acid dermal filler following contraction of COVID-19.